글로벌 바이러스 불활성화 시장 - 2028년까지의 산업 동향 및 예측

바이러스 불활성화 시장의 시장 분석 및 통찰력

Data Bridge Market Research는 바이러스 불활성화 시장이 2021-2028년 예측 기간 동안 약 12.44%의 CAGR을 보일 것이라고 분석했습니다. 제약 및 생명공학 기업에 대한 정부의 지원 증가, 연구 개발 능력에 대한 집중 증가, 첨단 의료 기술 도입 , 특히 개발도상국에서 의료 인프라 개발 에 대한 지출 증가가 바이러스 불활성화 시장 성장에 기여하는 주요 요인입니다.

바이러스 불활성화는 바이러스 제거 과정으로, 바이러스는 최종 제품에 남아 있을 수 있지만 비효과적인 형태로 남아 있을 수 있습니다. 바이러스 불활성화는 바이러스 제거 과정의 중요한 부분이며 모든 종류의 제약 약물에 사용됩니다.

만성 질환의 유병률이 전 세계적으로 급증하는 것은 시장 성장을 촉진하는 주요 요인 중 하나입니다. 제약 산업의 성장과 확장과 더불어 의료 기술 발전에 대한 집중이 높아지는 것은 또 다른 시장 성장 결정 요인입니다. 생명 과학 산업의 연구 개발 능력 향상, 나노 여과 기술에 대한 투자 급증, 신약의 상용화 증가, 주요 파이프라인 약물의 존재는 수익성 있는 시장 성장 기회를 더욱 창출할 것입니다.

그러나 생물학적 유사 제품을 제조하는 데 따른 높은 비용은 시장 성장을 저해하는 요인으로 작용할 것입니다. 저개발 지역에서 의료 전문성이 부족하면 시장 성장률이 더욱 떨어질 것입니다. 개발도상국과 저개발 경제권에서 불리한 상환 시나리오와 엄격한 규제 시나리오가 결합되어 시장에 더욱 큰 과제를 안겨줄 것입니다.

This viral inactivation market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on viral inactivation market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Viral Inactivation Market Scope and Market Size

The viral inactivation market is segmented on the basis of method, product, application and end user. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

• The global viral inactivation market is segmented on the basis of method into solvent detergent method, pasteurization and other viral inactivation method.
• On the basis of product, the viral inactivation market is segmented into kits and reagents, services, viral inactivation systems and accessories.
• On the basis of application, the viral inactivation market is segmented into blood and blood products, cellular and gene therapy products, stem cell products, tissue and tissue products, vaccines and therapeutics.
• The global viral inactivation market is segmented on the basis of end user into pharmaceutical and biotechnology companies, contract research organizations, blood banks, hospital, academic research institutes and other end users.

Viral Inactivation Market Country Level Analysis

The viral inactivation market is analysed and market size insights and trends are provided by country, method, product, application and end user as referenced above.

The countries covered in the viral inactivation market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the viral inactivation market in terms of market share and market revenue and will continue to flourish its dominance during the forecast period. This is because of the prevailing advanced healthcare technologies and rising research and development proficiencies. Asia-Pacific on the other hand is projected to exhibit the highest growth rate during the forecast period owing to the growing prevalence of chronic diseases and increased expenditure for the development of healthcare infrastructure.  

The country section of the viral inactivation market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure growth Installed base and New Technology Penetration

The viral inactivation market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for digital health technologies market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the viral inactivation market. The data is available for historic period 2010 to 2019.

Competitive Landscape and Viral Inactivation Market Share Analysis

The viral inactivation market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to viral inactivation market.

바이러스 불활성화 시장 보고서에서 다루는 주요 기업은 Merck & Co., Inc., PARKER HANNIFIN CORP, Sartorius AG, Texcell, Cytiva, Danaher., SGS SA, Charles River Laboratories., Cleancells, Rad Source Technologies, WuXi AppTec, GENERAL ELECTRIC COMPANY, Sigma-Aldrich Co., Thermo Fisher Scientific Inc., Macopharma, Cerus Corporation., TERUMO BCT, INC., Weigao group, SCI Automation., Pall Corporation, Eurofins Scientific 등 국내 및 글로벌 기업입니다. 시장 점유율 데이터는 글로벌, 북미, 유럽, 아시아 태평양(APAC), 중동 및 아프리카(MEA) 및 남미에 대해 개별적으로 제공됩니다. DBMR 분석가는 경쟁 우위를 이해하고 각 경쟁자에 대한 경쟁 분석을 개별적으로 제공합니다.

SKU-14398